Sea Moss for Behcet's Disease: Anti-Inflammatory, HLA-B51 Neutrophil Hyperactivation Vasculitis & Mineral Support

Behcet's disease (BD) is a systemic auto-inflammatory vasculitis affecting all vessel sizes (arterial aneurysms AND venous thrombosis — unique), driven by HLA-B51 genetic susceptibility, neutrophil hyperactivation (pathergy test), IL-1beta/IL-8/TNF-alpha/IL-17/IL-23 axis, NF-kB amplification, Th1/Th17 imbalance, CD8+ cytotoxic T lymphocyte expansion, mucosal barrier dysfunction (oral/genital microbiome), VCAM-1/ICAM-1 endothelial injury, occlusive venous thrombi (dural sinus thrombosis, Budd-Chiari), arterial aneurysms (pulmonary — life-threatening hemoptysis), CNS parenchymal inflammation (neuro-Behcet), uveitis with hypopyon (leading cause of blindness in endemic regions), and recurrent oral/genital ulcers (diagnostic hallmark). Sea moss fucoidan modulates NF-kB, IL-1beta/IL-17/IL-23, TNF-alpha, and neutrophil hyperactivation; selenium supports mucosal/vascular GPx defense; omega-3 EPA modulates IL-1beta and resolvin E1; zinc supports Treg and mucosal barrier. Colchicine first-line (mucocutaneous); azathioprine (eye/CNS); anti-TNF-alpha infliximab/adalimumab (uveitis/refractory); apremilast (mucocutaneous, FDA 2024); interferon-alpha for ocular.

Read the full guide